Government Employees Insurance Company (GEICO) and its affiliates have filed a lawsuit against New York pharmacy Emuna, Inc., doing business as Navar Pharmacy, and its owner, Javid Bamshad, alleging a scheme to defraud the insurer of millions of dollars.
According to the complaint, the defendants submitted more than $3.2 million in pharmaceutical claims under New York’s No-Fault insurance system. These claims allegedly involved high-cost topical medications prescribed to individuals involved in automobile accidents covered by GEICO policies. The complaint alleges that many of the prescriptions were medically unnecessary, issued without proper oversight, or issued without authorization. It further alleges that the defendants paid unlawful kickbacks to steer prescriptions to Navar Pharmacy.
The lawsuit describes Navar Pharmacy as part of a larger fraudulent operation managed by Bamshad and unidentified individuals referred to as John Doe Defendants. The scheme allegedly began in December 2021, when Bamshad entered into illegal arrangements with healthcare providers to channel prescriptions for specific, high-margin pharmaceuticals to the pharmacy.
GEICO claims that more than $2.6 million was billed for products such as Lidothol patches and Diclofenac solutions—medications the company describes as having high profit margins but questionable medical necessity. The complaint also alleges that some products were unapproved by the U.S. Food and Drug Administration or were sourced from unlicensed suppliers.
The plaintiffs seek restitution of over $1.6 million already paid and a judicial declaration that they are not obligated to pay an additional $1.13 million in pending claims submitted by Navar Pharmacy. They allege that the claims followed fraudulent protocols aimed at generating profit rather than providing appropriate care.
The plaintiffs are represented by attorneys Barry I. Levy, Michael A. Sirignano, Jennifer Abreu, and Brandon Barbaruolo of Rivkin Radler LLP. The case was filed in the United States District Court for the Eastern District of New York under Civil Action No. 1:25-cv-03373.